753 / 1224
/
No obvious differences in oncological outcome
•
Retrospective study
•
160 patients
•
SBRT: 54Gy in 3F
•
AHRT: 70.2Gy in
26Fx
No difference in any
in OS, RF, DF, LC
No difference in
toxicity
Lucas Lung Cancer 2014
Stereotactic Radiotherapy / Matthias Guckenberger 13.06.2016
SBRT compared to MODERN CF-RT